Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG5AM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $76,913
Award facts
- Contract value 100% obligated
- $76,913.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 26, 2026, with a ceiling value of $76,913.10 for OCREVUS 300 mg/10 mL vials.
The order is issued under the DLA Troop Support Medical IDC held by parent company Cencora, Inc., valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. The order carries an ultimate completion date of March 19, 2026 and is priced on a firm fixed-price basis.
Quick answers
Who was awarded contract SPE2DR26FG5AM?
SPE2DR26FG5AM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 26, 2026.
How much is contract SPE2DR26FG5AM worth?
The government has obligated $76,913 on SPE2DR26FG5AM.
Is contract SPE2DR26FG5AM an order under another contract?
Yes. SPE2DR26FG5AM is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG5AM competed?
The extent of competition for SPE2DR26FG5AM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award